MedPath

Comparing pulse rate measurement in newborns using conventional and dry electrode ECG monitors

Conditions
10028920
neonatal transition
hart rate monitoring
10028971
Registration Number
NL-OMON48339
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

Infants born at a gestational age at least 32 weeks who are evaluated on the
resuscitation table during neonatal transition at birth. The estimated birth
weight must be at least 1500 grams

Exclusion Criteria

Infants that have congenital abnormalities of the thorax, an estimated foetal
weight of less than 1500 grams, or are withheld life support at birth

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Correlation of all pulse rate measurements of the Neobeat, ECG monitor and<br /><br>pulse oximetry device:<br /><br>All continuous data will be compared during the first 10 minutes after birth.<br /><br>The relationship between the three devices will be evaluated using Bland-Altman<br /><br>bias analysis; the difference between the measurements will be plotted against<br /><br>their average. The sensitivity, specificity, positive predictive values, and<br /><br>negative predictive values of measurements collected using the Neobeat, ECG and<br /><br>pulse oximetry for detecting HRECG <100 bpm will be calculated.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>1) Correlation between signals of the three monitoring devices over time.<br /><br>All continuous data will be compared during the first 10 minutes after birth.<br /><br>Data will be plotted over time and averaged for 30 second intervals and plotted<br /><br>for each different monitoring device. Data will be compared using an Anova for<br /><br>multiple continuous normally distributed values<br /><br><br /><br>2) Duration from application until a reliable signal is acquired.<br /><br>The time until the first reliable signal is acquired is averaged for all three<br /><br>devices and compared using an ANOVA for normally distributed values. The<br /><br>Friedmans* test will be used for non-normally distributed data. </p><br>
© Copyright 2025. All Rights Reserved by MedPath